⌘K

Home/Filings/4/0001415889-25-002230

4//SEC Filing

ALEXANDER MARGARET A. 4

Accession 0001415889-25-002230

CIK 0001636651other

View on SEC.gov Company Profile

Filed

Jan 28, 7:00 PM ET

Accepted

Jan 29, 9:18 AM ET

Size

4.6 KB

Accession

0001415889-25-002230

Insider Transaction Report

Form 4

Period: 2025-01-27

Ovid Therapeutics Inc.OVID

ALEXANDER MARGARET A.

DirectorPresident and CEO

Transactions

Purchase
Common Stock
2025-01-27$0.73/sh+6,810$4,971→ 34,935 total

Documents

1 file

4
form4-01292025_020104.xmlPrimary

Issuer

Ovid Therapeutics Inc.

CIK 0001636651

Entity typeother

Related Parties

1

filerCIK 0002036798

Filing Metadata

Form type: 4
Filed: Jan 28, 7:00 PM ET
Accepted: Jan 29, 9:18 AM ET
Size: 4.6 KB

View on SEC.gov